Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Neuraminidase-IN-13 (Compound 10), a neuraminidase inhibitor exhibiting antiviral activity, demonstrates significant inhibition of NDV infection in Vero cells with minimal cytotoxicity by impeding the release of viral particles from infected cells [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Neuraminidase-IN-13 (Compound 10), a neuraminidase inhibitor exhibiting antiviral activity, demonstrates significant inhibition of NDV infection in Vero cells with minimal cytotoxicity by impeding the release of viral particles from infected cells [1]. |
In vitro | Neuraminidase-IN-13 inhibits plaque formation in the NDV La Sota strain with an IC50 of 0.06 µM [1]. It also suppresses viral replication with an IC50 of 0.04 µM [1] and demonstrates no cytotoxicity on cells, with a CC50 value greater than 2500 µM [1]. Furthermore, Neuraminidase-IN-13 impedes viral attachment to Vero cells, having an IC50 of 4 µM [1], and obstructs the release of the virus from Vero cells with an IC50 of 0.09 µM [1]. |
Molecular Weight | 470.25 |
Formula | C13H13F7N4O7 |
CAS No. | 2222067-23-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Neuraminidase-IN-13 2222067-23-2 Microbiology/Virology Influenza Virus inhibitor inhibit